Sains Malaysiana 50(5)(2021): 1425-1431

http://doi.org/10.17576/jsm-2021-5005-21

 

Ascites in a Patient with Hairy Cell Leukaemia and Carcinoma of Breast: A Diagnostic Challenge

(Asites pada Pesakit Leukaemia Sel Berbulu dan Karsinoma Payudara: Suatu Cabaran Diagnosis)

 

WINT WINT THU NYUNT1, AZIAN NAILA BINTI MD NOR2, NORALISA ABDUL KARIM1, TANG YEE LOONG2, S FADILAH S ABDUL WAHID1* & NOR RAFEAH TUMIAN3

 

1Pusat Terapi Sel, Faculty of Medicine, Hospital Canselor Tuanku Muhriz UKM, 56000 Kuala Lumpur, Federal Territory, Malaysia

 

2Department of Pathology, Faculty of Medicine, Hospital Canselor Tuanku Muhriz UKM, 56000 Kuala Lumpur, Federal Territory, Malaysia

 

3Department of Medicine, Faculty of Medicine, Hospital Canselor Tuanku Muhriz UKM, 56000 Kuala Lumpur, Federal Territory, Malaysia  

Received: 3 January 2020/Accepted: 30 September 2020

 

ABSTRACT

Hairy cell leukaemia (HCL) is a rare indolent B-cell lymphoproliferative disorder. We report a diagnostic challenge in detecting the cause of ascites, which is a rare, unique manifestation of HCL. A 72-year-old lady presented with 1-month-history of pain in left upper abdomen and loss of weight. There was hepatomegaly, splenomegaly, bilateral inguinal lymphadenopathy, anaemia, and lymphocytosis. She was diagnosed as HCL, based on morphology, immunophenotyping of peripheral blood and bone marrow biopsy examination. In 2009, she was diagnosed as carcinoma of breast when she presented with a mass in left breast; and she received treatment. For HCL, she received intermittent chemotherapy (Chlorambucil+Prednisolone). Her HCL was stable until 2018 when she presented with recurrent ascites which needed frequent, regular peritoneal paracentesis. Since she had HCL and carcinoma of breast, determining the aetiology of ascites was challenging. Possible causes of her ascites included metastatic carcinoma of breast, HCL, cirrhosis of liver with portal hypertension and peritoneal tuberculosis. Cytology of peritoneal fluid showed mature-looking lymphocytes but no malignant cells. Interestingly, flow cytometry analysis of peritoneal fluid showed the presence of clonal B cell population with lambda light chain restriction. Therefore, it was concluded that her ascites was a manifestation of HCL. A few months later, she succumbed to septicaemia. Impact of ascites on disease course of HCL included rapid disease progression, poor prognosis and shortened survival. We highlight the important role of immunophenotyping in addition to cytomorphology to guide us in confirming the aetiology of ascites in a patient with haematological and solid organ malignancies.

 

Keywords: Ascites; flow cytometry; hairy cell leukaemia; immunophenotyping

 

ABSTRAK

Leukaemia sel berbulu (HCL) merupakan penyakit limfoproliferatif sel-B indolen yang jarang berlaku. Kami melaporkan cabaran diagnosis dalam mengesan penyebab asites, iaitu manifestasi HCL yang luar biasa dan unik. Seorang wanita berumur 72 tahun menunjukkan sejarah kesakitan di bahagian kiri atas abdomen selama sebulan dan penurunan berat badan. Terdapat hepatomegali, splenomegali, limfadenopati inguinal bilateral, anaemia dan limfositosis. Beliau didiagnos sebagai HCL berdasarkan morfologi, imunofenotip darah periferi dan pemeriksaan biopsi sumsum tulang. Pada tahun 2009, beliau didiagnos pula dengan karsinoma payudara apabila terdapat gumpalan pada payudara kiri dan beliau telah menerima rawatan. Bagi HCL, beliau menerima kemoterapi bersela (Chlorambucil+Prednisolone). Penyakit HCL beliau stabil sehingga tahun 2018 apabila beliau mengalami asites berulang dan memerlukan parasentesis peritoneum yang kerap. Oleh kerana beliau menghidap HCL dan karsinoma payudara, penentuan etiologi asites tersebut menjadi amat mencabar. Beberapa kemungkinan punca asitesnya termasuklah metastasis karsinoma payudara, HCL, sirosis hati dengan hipertensi portal dan tuberkulosis peritoneum. Ujian sitologi cecair peritoneum menunjukkan limfosit yang kelihatan matang namun tiada sel malignan. Menariknya, analisis sitometri aliran cecair peritoneum menunjukkan kehadiran populasi sel B klonal dengan sekatan rantai ringan lambda. Oleh itu, disimpulkan bahawa asites tersebut merupakan manifestasi HCL. Beberapa bulan kemudian, beliau meninggal dunia akibat septisemia. Kesan asites pada penyakit HCL termasuklah perkembangan penyakit yang pantas, prognosis yang buruk dan kelangsungan hidup yang pendek. Kami menekankan kepentingan imunofenotip selain sitomorfologi dalam membimbing kami untuk mengesahkan etiologi asites pada pesakit haematologi dan kemaglinanan organ pejal.

 

Kata kunci: Asites; imunofenotip; leukaemia sel berbulu; sitometri aliran

 

REFERENCES

Arora, N., Mishra, A., Santra, P. & Nair, R. 2015. Hairy cell leukaemia with ascites and coexistent histoplasmosis. Indian Journal of Pathology and Microbiology 58(1): 125-126.

Au, W.Y., Klasa, R.J., Gallagher, R., Le, N., Gascoyne, R.D. & Connors, J.M. 1998. Second malignancies in patients with hairy cell leukaemia in British Columbia: A 20-year experience. Blood 92(4): 1160-1164.

Bouroncle, B.A. 1987. Unusual presentations and complications of hairy cell leukaemia. Leukaemia 1(4): 288-293.

Cesana, C., Klersy, C., Scarpati, B., Brando, B., Volpato, E., Bertani, G., Faleri, M., Nosari, A., Cantoni, S., Ferri, U. & Scampini, L. 2010. Flow cytometry vs cytomorphology for the detection of haematologic malignancy in body cavity fluids. Leukaemia Research 34(8):  1027-1034.

Cornet, E., Tomowiak, C., Tanguy‐Schmidt, A., Lepretre, S., Dupuis, J., Feugier, P., Devidas, A., Mariette, C., Leblond, V., Thiéblemont, C. & Validire‐Charpy, P. 2014. Long‐term follow‐ up and second malignancies in 487 patients with hairy cell leukaemia. British Journal of Haematology 166(3): 390-400.

Davies, G.E. & Wiernik, P.H. 1977. Hairy cell leukaemia with chylous ascites. JAMA 238(14): 1541-1542.

Dinçol, G., Dogan, Ö., Küçükkaya, R.D., Gül, E., Kahraman, R. & Agan, M. 2008. Hairy cell leukaemia presenting with ascites, pleural effusion and increased CA 125 serum level. The Netherlands Journal of Medicine 66(1): 23-26.

Grever, M.R., Abdel-Wahab, O., Andritsos, L.A., Banerji, V., Barrientos, J., Blachly, J.S., Call, T.G., Catovsky, D., Dearden, C., Demeter, J., Else, M., Forconi, F., Gozzetti, A., Ho, A.D., Johnston, J.B., Jones, J., Juliusson, G., Kraut, E., Kreitman, R.J., Larratt, L., Lauria, F., Lozanski, G., Montserrat, E., Parikh, S.A., Park, J.H., Polliack, A., Quest, G.R., Rai, K.R., Ravandi, F., Robak, T., Saven, A., Seymour, J.F., Tadmor, T., Tallman, M.S., Tam, C., Tiacci, E., Troussard, X., Zent, C.S., Zenz, T., Zinzani, P.L. & Falini, B. 2017. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukaemia. Blood 129(5): 553-560.

Kayal, S., Radhakrishnan, V., Singh, S., Chopra, A., Kumar, R. & Raina, V. 2011. Hairy cell leukaemia with ascites: An unusual presentation. Leukaemia & Lymphoma 52(3): 539-540.

Maitre, E., Cornet, E. & Troussard, X. 2019. Hairy cell leukaemia: 2020 update on diagnosis, risk stratification, and treatment. American Journal of Hematology 94(12): 1413-1422.

Morton, L.M., Wang, S.S., Devesa, S.S., Hartge, P., Weisenburger, D.D. & Linet, M.S. 2006. Lymphoma   incidence   patterns   by   WHO   subtype   in   the   United   States, 1992-2001. Blood 107(1): 265-276.

Saven, A., Burian, C., Koziol, J.A. & Piro, L.D. 1998. Long-term follow-up of patients with hairy cell leukaemia after cladribine treatment. Blood 92(6): 1918-1926.

Shackelford, R.E., Heldmann, M., Eskandari, F., Joshi, N., Browning, J., Maxwell, N. & Coteligam, J. 2013. Marked retroperitoneal lymphadenopathy in hairy cell leukaemia: A        case report. Case Reports in Oncology 6(3): 493-496.

Tong, L.C., Ko, H.M., Saieg, M.A., Boerner, S., Geddie, W.R. & da Cunha Santos, G. 2013. Subclassification of lymphoproliferative disorders in serous effusions: A 10‐year experience. Cancer Cytopathology 121(5): 261-270.

Weissman, G.S., McKinley, M.J., Budman, D.R., Caccese, W.J., Schulman, P., Grueneberg, D. & Bronzo, R.L. 1987. Flow cytometry. A new technique in the diagnosis of malignant ascites. Journal of Clinical Gastroenterology 9(5): 599-602.

 

*Corresponding author; email: sfadilah@ppukm.ukm.edu.my

 

 

 

previous